Vitalea Science

Vitalea Science is a global Bioanalytical Contract Research Organization that uses Accelerator Mass Spectrometry (AMS) technology to

Vitalea Science is a global Bioanalytical Contract Research Organization that uses Accelerator Mass Spectrometry (AMS) technology to dramatically reduce the timeline to bring new drugs to market. We have a proven record with complex analyses and a culture driven by timelines and data of the highest integrity. Vitalea Science in Pediatric Research The recent article 'Applications of accelerator MS in pediatric drug evaluation,' Vuong L, Blood A, Vogel J, Anderson M, Goldstein B. (2012) Bioanalysis 4(15):1871-82 details the challenges, clinical successes and future perspectives on making drugs safer and more available to children. The full article is available by emailing Ann Hoffman at [email protected]. Eckert & Ziegler Acquires Vitalea Science Inc. as Part of Strategic Move into Innovative Pharmaceutical Services Vitalea Science, a leading provider of bioanalytical services for the pharmaceutical industry based on Accelerator Mass Spectrometry (AMS) technology, was fully acquired as of September 1, 2012 by Berlin based Eckert Ziegler (EZ) and is now part of the Isotope Products (EZIP) division. The publicly traded company has shown outstanding revenue growth in its core areas of isotope products for medical devices and specialized cancer treatments over its 45 year history. Vitalea is well supported by EZIP’s timeline driven service strategy that provides the culture for growth and stability for the future.